NewsBenzingaImmunocore、2026年SITC年次総会にて、HLA-A*02:01陽性の転移性ぶどう膜黒色腫患者を対象に、ブレネタフスプ単剤およびKIMMTRAKとの併用を評価した第1/2相試験データを発表へ Immunocore、2026年SITC年次総会にて、HLA-A*02:01陽性の転移性ぶどう膜黒色腫患者を対象に、ブレネタフスプ単剤およびKIMMTRAKとの併用を評価した第1/2相試験データを発表へ Benzinga 2026.10.29 13:04 (GMT+0) Open on Benzinga Other news AI models can be tricked into identifying civilians as military targets by telling them it’s a game Why Nvidia Is Falling Tuesday: Jensen Huang’s Comeback Statement, Congress Hearings, and AI Risks General Motors Plans 20% Boost In Robotics As Factory Costs Rise Eli Lilly Inks Multibillion-Dollar Pact to Develop Precision Cancer Therapies McKesson Stock Is a Triple Threat at New All-Time Highs. How to Trade It Here. 'Nvidia stopped disclosing Singapore sales as revenues hit $104B' -FT